The retooled Covid-19 booster from Pfizer Inc. and BioNTech SE generated a strong immune response against the Omicron substrains BA.4 and BA.5, the companies said.

The data, which the companies reported in a news release Thursday, offer the first window into how the new shots rolling out across the U.S. perform.

This post first appeared on wsj.com

You May Also Like

With X under fire, Elon Musk digs in and finds support from conservatives

As advertisers continue to back away from X following concerns around antisemitism…

WWE’s ‘SmackDown’ to Move to NBCUniversal’s USA From Fox

What to Read Next This post first appeared on wsj.com

How Close Is Too Close for a Flight Connection?

Life & Work Travel Carry On Big crowds and large new airport…

In a first, London Marathon to award wheelchair and non-disabledd athletes equal prize money

LONDON — In a global first for equality in sports, wheelchair athletes…